Delivery Order SPE2DB24D1007-SPE2DB25FCDBA
- Not listed
- The Defense Logistics Agency awarded a $15,593.79 delivery order to AmerisourceBergen Drug Corp for 60-tablet units of Eliquis 5 mg tablets, with an ultimate completion date of August 4, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's existing pharmaceutical supply arrangements with DLA. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a $11,794.32 delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Eliquis 5 mg tablets (60-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation, requiring completion by July 31, 2025. AmerisourceBergen will fulfill this order from its Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor serving...
- The Defense Logistics Agency awarded a $33,624.70 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, with an ultimate completion date of August 18, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The award was made to AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, the company's headquarters, where it maintains significant pharmaceutical distribution operations supporting federal medical...
- The Defense Logistics Agency awarded a $17,742.12 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg on August 22, 2025, with an ultimate completion date of August 25, 2025. This competitive award utilizes firm fixed pricing and carries no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a prime contractor under the agency's pharmaceutical supply chain and fulfills this order from its corporate office location. This...
- The Defense Logistics Agency awarded a delivery order valued at $19,111.33 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units). This contract, executed on July 29, 2025, with an ultimate completion date of July 30, 2025, utilizes firm fixed-price pricing and was competitively awarded without any set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Eliquis 5 mg tablets (60-count units) at a firm fixed price ceiling value of $25,069.77. This non-set-aside, competitively awarded contract is scheduled for completion by August 15, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $10,533.97 for 60 tablets of Eliquis 5 mg on August 18, 2025, with completion scheduled for August 19, 2025. This is a firm fixed price, non-set-aside contract utilizing a competitive award process. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $15,801.10 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) under a firm fixed-price contract type. The award was made on August 5, 2025, with an ultimate completion date of August 6, 2025, and carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania serves as the place of performance for this...
- The Defense Logistics Agency awarded a $15,808.62 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a commonly prescribed anticoagulant medication. The contract was executed on August 13, 2025, with an ultimate completion date of August 14, 2025, and carries firm fixed pricing under a non-set-aside competitive award. Performance of the contract is based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $11,258.62 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages). The contract is a firm fixed price delivery order with an ultimate completion date of July 31, 2025, and was competitively awarded with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same municipality. This delivery order...
- SPE2DB24D1007Indefinite Delivery Contract
- SPE2DB24D1007-SPE2DB25FCDBADelivery Order
The Defense Logistics Agency awarded a $37,925.93 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, with an ultimate completion date of September 3, 2025. This is a firm fixed-price contract with no set-aside designation, competitively awarded to the prime contractor. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the pharmaceutical distributor maintains its headquarters and primary operations. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.999 billion through December 2026. As a critical vendor in the federal pharmaceutical supply chain, AmerisourceBergen serves multiple federal agencies including the Defense Health Agency and U.S. Coast Guard through this comprehensive global pharmaceutical support vehicle. The contract enables delivery of brand-name and generic medications, vaccines, and medical supplies to support military healthcare programs worldwide, with Eliquis—an anticoagulant medication—representing one of many pharmaceutical products supplied under this framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $37.9k | 9/2/25 |